Company name: Molecular Science
Description: Owner and operator of a private cannabis life sciences company created to focus on product development, terpenes and plant genetics as well as lab integration software. The company’s activities include utilization of advanced genetic, genomic and physiological techniques to better understand cannabis plant and terpenoid compounds in order to offer licensed product testing using Ample Labs software, strains with desired traits and clinical research demonstrating results, enabling cannabis industry to have access to tools for production and distribution of cannabis based probiotics.
Year founded: 2017
Industry: Information Technology | Group: Software | Code:
Start up capital raised (USD Million): 0.02
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company reached a definitive agreement to acquire Ateba Resources (TSX: ATR) through a reverse merger, resulting in the combined entity trading on the TSX Stock Exchange on August 15, 2018. The closing date for the transaction is expected to be on or around October 31, 2018.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: